Ubs Asset Management Americas Inc Pharvaris N.V. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Pharvaris N.V. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 63,734 shares of PHVS stock, worth $985,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,734
Previous 48,896
30.35%
Holding current value
$985,327
Previous $905,000
34.92%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$116 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$68 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$66.3 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$56.5 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$51.1 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $522M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...